Journal of Cardiovascular Pharmacology and Therapeutics: 2023, vol: 28, issue:
- 1)- Rupert M Bauersachs. Fondaparinux Sodium: Recent Advances in the Management of Thrombosis. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484221145010
Cited : 16Read More - 2)- Koichiro Matsumura, Takeshi Ijichi, Junko Morimoto, Kensuke Takabayashi, Mitsunori Miho, Keisuke Ueno, Eijiro Yagi, Toru Takase, Masafumi Ueno, Gaku Nakazawa. Up-Titration of Sacubitril/Valsartan Among Patients With Heart Failure and Preserved Ejection Fraction. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484221146375Cited : 2Read More
- 3)- Xueyuan Yang, Chao Feng, Jinping Feng. Epicardial Adipose Tissue and Diabetic Cardiomyopathy. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231151820Cited : 3Read More
- 4)- Wangde Dai, Jianru Shi, Prabha Siddarth, Lifu Zhao, Juan Carreno, Michael T Kleinman, David A Herman, Rebecca J Arechavala, Samantha Renusch, Irene Hasen, Amanda Ting, Robert A Kloner. Effects of Electronic Cigarette Exposure on Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231155992Cited : 10Read More
- 5)- Jabeur Methnani, Marwa Hajbelgacem, Taieb Ach, Faten Chaieb, Sana Sellami, Ali Bouslama, Monia Zaouali, Asma Omezzine, Ezdine Bouhlel. Effect of Pre-Meal Metformin With or Without an Acute Exercise Bout on Postprandial Lipemic and Glycemic Responses in Metabolic Syndrome Patients: A Randomized, Open Label, Crossover Study. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231156318Cited : 1Read More
- 6)- Hani Sabbour, Aftab Ahmad. Management of Heart Failure in Patients With Diabetes Mellitus in the UAE: A Call to Action. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231162248Cited : 0Read More
- 7)- Xiao Wang, Zuqing Xu, Rong Chang, Changchun Zeng, Yanli Zhao. High-Fructose Diet Induces Cardiac Dysfunction via Macrophage Recruitment in Adult Mice. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231162249Cited : 6Read More
- 8)- Yuanyuan Zeng, Jing Zhao, Jingfang Zhang, Tingting Yao, Jieqiong Weng, Mengfei Yuan, Xiaoxu Shen. Development of a Nomogram That Predicts the Risk of Coronary Heart Disease in Patients With Hyperlipidemia. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231167754Cited : 2Read More
- 9)- João Pedro Faria, Pedro Oliveira, André Alexandre, David Sá Couto, Ricardo Costa, Andreia Campinas, André Frias, Bruno Brochado, Raquel Santos, João Silveira, Severo Torres, André Luz. Ticagrelor Loading on ST-Elevation Myocardial Infarction: Interaction With Prodromal Angina on Infarct Size and Clinical Events. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231169644Cited : 0Read More
- 10)- Maofeng Gong, Qing Zhao, Rui Jiang, Zhengli Liu, Boxiang Zhao, Jie Kong, Xu He, Jianping Gu. Endovascular Therapies Using Catheter-Based Thrombectomy or Catheter-Directed Thrombolysis for Acute Non-Cancer Associated Inferior Vena Cava Thrombosis: A Retrospective Cohort Study. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231171579Cited : 0Read More
- 11)- Vladimír Blaha, Roman Margoczy, Ivo Petrov, Arman Postadzhiyan, Katarína Rašlová, Hana Rosolová, Ian Bridges, Nafeesa N Dhalwani, Marie Zachlederova, Kausik K Ray. Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231172847Cited : 0Read More
- 12)- Zuo-Zhong Yu, Zheng-Xiong Xu, Yue-Hua Ruan, Long-Long Hu, Ming-Hua Wen, Tie-Qiu Huang, Zhi-Gang You, Yan-Qing Wu, Ren-Qiang Yang. Protective Effect of Nicorandil on Contrast-Induced Acute Kidney Injury After Emergency Percutaneous Coronary Intervention. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231174296Cited : 1Read More
- 13)- Gerd Heusch. Cardioprotection and its Translation: A Need for New Paradigms? Or for New Pragmatism? An Opinionated Retro- and Perspective. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231179613Cited : 11Read More
- 14)- Qian Hao, Zhao Yuanyuan, Chen Lijuan. The Prognostic Value of the Triglyceride Glucose Index in Patients With Acute Myocardial Infarction. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231181846Cited : 10Read More
- 15)- Qi Lou, Luyifei Li, Guangzhong Liu, Tiankai Li, Li Zhang, Yanxiang Zang, Chengchuang Zhan, Hong Wang, Weimin Li. Vericiguat reduces electrical and structural remodeling in a rabbit model of atrial fibrillation. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231185252Cited : 5Read More
- 16)- Qihong Liang, Lulan Li, Kerong Chen, Sheng An, Zhiya Deng, Jiaxin Li, Shiyu Zhou, Zhongqing Chen, Zhenhua Zeng, Shengli An. Effect of Esmolol on Clinical Outcomes in Critically Ill Patients: Data from the MIMIC-IV Database. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231185985Cited : 0Read More
- 17)- Rosaria Vincenza Giglio, Emir M Muzurović, Angelo Maria Patti, Peter P Toth, Manyoo A Agarwal, Wael Almahmeed, Aleksandra Klisic, Marcello Ciaccio, Manfredi Rizzo. Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231186855Cited : 5Read More
- 18)- Yonghong Luo, Daoquan Peng. Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231189597Cited : 3Read More
- 19)- Noor Muhammad Azlan Shah Bin Atan, Mohd Firdaus Bin Hadi, Victoria Wen Yeng Teoh, Mahmoud Danaee, Alexander Loch. ARNI Versus Perindopril for Remodeling in HFrEF. A Cohort Study. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231195019Cited : 0Read More
- 20)- Jia Cheng, Lin Qiu, Zixuan Zhang, Na Li, Hongyang Shu, Zhichao Xiao, Ning Zhou. Combination of Nicorandil and Beta-Adrenergic Receptor Blockers in Patients with Coronary Artery Disease: A Real-World Observational Study. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231197559Cited : 0Read More
- 21)- Zohair Al Aseri, Farjah H AlGahtani, Majid F Bakheet, Ahmed H Al-Jedai, Sarah Almubrik. Evidence-based Management of Major Bleeding in Patients Receiving Direct Oral Anticoagulants: An Updated Narrative Review on the Role of Specific Reversal Agents. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231202655Cited : 1Read More
- 22)- Byung Jin Kim, Kwang Soo Cha, Wook Hyun Cho, Eung Ju Kim, Seung-Hyuk Choi, Moo Hyun Kim, Sang-Hyun Kim, Jun-Bean Park, Seong-Mi Park, Il Suk Sohn, Kyu Hyung Ryu, In-Ho Chae. Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231205204Cited : 0Read More
- 23)- Jaouad Azzahhafi, Wout W A van den Broek, Dean R P P Chan Pin Yin, Ankie M Harmsze, Ron H N van Schaik, Jurriën M Ten Berg. The Clinical Implementation of Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231210704Cited : 4Read More
- 24)- Ruslan B Strutynskyi, Nataliіa A Strutynska, Oksana O Piven, Lidiia A Mys, Yulia V Goshovska, Raisa A Fedichkina, Iryna Y Okhai, Vladyslav R Strutynskyi, Victor E Dosenko, Pawel Dobrzyn, Vadim F Sagach. Upregulation of ATP-Sensitive Potassium Channels as the Potential Mechanism of Cardioprotection and Vasorelaxation Under the Action of Pyridoxal-5-Phosphate in Old Rats. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231213175Cited : 2Read More
- 25)- Juan A Peraza-Zaldivar, Juan M Ponce-Guarneros, Ernesto G Cardona-Muñoz, Yussef Esparza-Guerrero, Ana M Saldaña-Cruz, Sergio A González-Vazquez, Laura Gonzalez-Lopez, Jorge I Gamez-Nava, Norma A Rodriguez-Jimenez. Effects of Renin-Angiotensin System Inhibitors on Atrial Mechanics Parameters in Patients with Metabolic Syndrome. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231216807Cited : 0Read More
- 26)- Changchun Hou, Xinxin Hao, Ning Sun, Xiaolin Luo, Zhichun Gao, Ling Chen, Xi Liu, Zhexue Qin. Predicting Hospital Readmissions in Patients Receiving Novel-Dose Sacubitril/Valsartan Therapy: A Competing-Risk, Causal Mediation Analysis. Journal of cardiovascular pharmacology and therapeutics. 2023, 28: 10742484231219603Cited : 0Read More
